annual EBIT:
-$3.08M+$64.44M(+95.43%)Summary
- As of today (June 25, 2025), SPRY annual earnings before interest & taxes is -$3.08 million, with the most recent change of +$64.44 million (+95.43%) on December 31, 2024.
- During the last 3 years, SPRY annual EBIT has risen by +$16.37 million (+84.15%).
- SPRY annual EBIT is now -557.36% below its all-time high of -$469.00 thousand, reached on December 1, 2020.
Performance
SPRY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$37.18M-$84.37M(-178.77%)Summary
- As of today (June 25, 2025), SPRY quarterly earnings before interest & taxes is -$37.18 million, with the most recent change of -$84.37 million (-178.77%) on March 31, 2025.
- Over the past year, SPRY quarterly EBIT has dropped by -$23.98 million (-181.81%).
- SPRY quarterly EBIT is now -178.77% below its all-time high of $47.20 million, reached on December 31, 2024.
Performance
SPRY quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$27.07M-$23.98M(-777.98%)Summary
- As of today (June 25, 2025), SPRY TTM earnings before interest & taxes is -$27.07 million, with the most recent change of -$23.98 million (-777.98%) on March 31, 2025.
- Over the past year, SPRY TTM EBIT has increased by +$34.93 million (+56.34%).
- SPRY TTM EBIT is now -777.98% below its all-time high of -$3.08 million, reached on December 31, 2024.
Performance
SPRY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SPRY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.4% | -181.8% | +56.3% |
| 3 y3 years | +84.2% | -423.7% | -281.3% |
| 5 y5 years | -557.4% | - | - |
SPRY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.4% | -178.8% | at low | -778.0% | +62.8% |
| 5 y | 5-year | -557.4% | +95.4% | -178.8% | at low | -778.0% | +62.8% |
| alltime | all time | -557.4% | +95.4% | -178.8% | at low | -778.0% | +62.8% |
SPRY EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$37.18M(-178.8%) | -$27.07M(+778.0%) |
| Dec 2024 | -$3.08M(-95.4%) | $47.20M(-317.0%) | -$3.08M(-94.9%) |
| Sep 2024 | - | -$21.75M(+41.8%) | -$60.51M(+6.6%) |
| Jun 2024 | - | -$15.34M(+16.3%) | -$56.74M(-8.5%) |
| Mar 2024 | - | -$13.19M(+29.0%) | -$62.00M(-8.2%) |
| Dec 2023 | -$67.52M | -$10.23M(-43.1%) | -$67.52M(-7.2%) |
| Sep 2023 | - | -$17.98M(-12.7%) | -$72.74M(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$20.60M(+10.1%) | -$61.39M(+30.3%) |
| Mar 2023 | - | -$18.71M(+21.2%) | -$47.13M(+32.7%) |
| Dec 2022 | -$35.52M(+82.6%) | -$15.44M(+132.9%) | -$35.52M(+76.9%) |
| Sep 2022 | - | -$6.63M(+4.5%) | -$20.07M(+49.3%) |
| Jun 2022 | - | -$6.34M(-10.6%) | -$13.44M(+89.4%) |
| Mar 2022 | - | -$7.10M | -$7.10M |
| Dec 2021 | -$19.45M(+4048.0%) | - | - |
| Dec 2020 | -$469.00K | - | - |
FAQ
- What is ARS Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual EBIT year-on-year change?
- What is ARS Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly EBIT year-on-year change?
- What is ARS Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM EBIT year-on-year change?
What is ARS Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SPRY is -$3.08M
What is the all time high annual EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual earnings before interest & taxes is -$469.00K
What is ARS Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SPRY annual earnings before interest & taxes has changed by +$64.44M (+95.43%)
What is ARS Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SPRY is -$37.18M
What is the all time high quarterly EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly earnings before interest & taxes is $47.20M
What is ARS Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SPRY quarterly earnings before interest & taxes has changed by -$23.98M (-181.81%)
What is ARS Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SPRY is -$27.07M
What is the all time high TTM EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM earnings before interest & taxes is -$3.08M
What is ARS Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SPRY TTM earnings before interest & taxes has changed by +$34.93M (+56.34%)